✦ LIBER ✦

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis

✍ Scribed by Wen-Yi Li; Tzong-Shinn Chu; Jenq-Wen Huang; Ming-Shiou Wu; Kwan-Dun Wu

Book ID: 117630450
Publisher: Chinese Electronic Periodical Services
Year: 2008
Tongue: English
Weight: 210 KB
Volume: 107
Category: Article
ISSN: 0929-6646
DOI: 10.1016/s0929-6646(08)60200-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from Recombinant Human Erythr

Conversion from Recombinant Human Erythropoietin to Once Every 4 Weeks Darbepoetin Alfa for Treatment of Renal Anemia in CAPD Patients

✍ Hon-Lok Tang; Ka-Shun Fung; Kwok-Hong Chu; William Lee; Au Cheuk; Ka-Fai Yim; Hi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Randomized trial of darbepoetin alfa for

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

✍ Vanrenterghem, Yves; BÃ¡rÃ¡ny, Peter; Mann, Johannes F.E.; Kerr, Peter G.; Wilso 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 601 KB

## Background: Darbepoetin alfa is a glycoprotein with a three-fold longer terminal half-life than recombinant human erythropoietin (rhuepo). we aimed to determine whether darbepoetin alfa is as effective and well tolerated as rhuepo for treating renal anemia in dialysis patients when administered

A retrospective study of clinical use of

A retrospective study of clinical use of recombinant human erythropoietin for treatment of anemia in dogs with renal failure in Bangkok, Thailand

✍ Sukullaya Assarasakorn; Morakot Kaewthamasorn; Anuchai Niwetpathomwat 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 123 KB

Unit dosing of darbepoetin alfa for thet

Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients

✍ Georgios Bristoyiannis; Nikolaos Germanos; Dimitrios Grekas; Christos Hatzidimit 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 930 KB

A 6-month study of low-dose recombinant

A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients

✍ William J. Gaughan; Kenneth A. Liss; Stephen R. Dunn; Antonia M. Mangold; Judith 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 552 KB